Trial challenges 6-Month TB treatment rule for thousands
NCT ID NCT07163143
Summary
This trial aims to find the best way to treat people who have early signs of tuberculosis (TB) on a chest X-ray but whose sputum tests come back negative. It will test whether shorter courses of TB drugs (from 8 to 24 weeks) work as well as the standard 6-month treatment, or if careful monitoring without immediate drugs is a safe option. The study will follow 784 people in South Africa, Zimbabwe, and Pakistan for 78 weeks to see which approach best prevents the disease from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS (TB) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bulawayo City Health
Bulawayo, Zimbabwe
Contact Email: •••••@•••••
-
Clinical HIV Research Unit, Wits Health Consortium
Johannesburg, South Africa
Contact Email: •••••@•••••
-
National University of Medical Sciences
Islamabad, Pakistan
Contact Email: •••••@•••••
-
The Aurum Institute
Johannesburg, South Africa
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.